Diagnostic imaging in the differential diagnosis of vaginal bleeding and breast mass

Advanced Studies in Medicine

Volumn 4, Issue 9, 2004, Pages 476-482

  Smith Bindman, Rebecca ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HORMONE;

BIOPSY TECHNIQUE; BLEEDING; BREAST CANCER; BREAST CYST; BREAST TUMOR; CANCER DIAGNOSIS; CANCER RISK; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; ECHOMAMMOGRAPHY; ENDOMETRIUM CANCER; ENDOMETRIUM HYPERPLASIA; EXCISIONAL BIOPSY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEMATOMA; HUMAN; HYSTEROSCOPY; INFECTION; MALPRACTICE; META ANALYSIS; PALPATION; PHYSICIAN; POSTMENOPAUSE; PRIMARY MEDICAL CARE; REVIEW; SCAR FORMATION; SYMPTOMATOLOGY; TRANSVAGINAL ECHOGRAPHY; UTERUS CANCER; VAGINA BLEEDING;

EID: 6344285460     PISSN: 15303004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Karlsson B, Granberg S, Wikland M, et al. Gynecology: Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding - a Nordic multicenter study. Am J Obstet Gynecol. 1995;172:1488-1494.
2. Smith-Bindman R, Kerlikawske K, Feldstein VA, et al. Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA. 1998;280:1510-1517.
3. Al-Azzawi F, Habiba M. Regular bleeding on hormone replacement therapy: a myth? Br J Obstet Gynaecol. 1994;101:661-662.
4. Hickey M, Pillai G, Higham JM, et al. Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding. Hum Reprod. 2003;18:1100-1006.
5. Rose PG. Endometrial carcinoma. N Engl J Med. 1996;335:640-649.
6. National Institutes of Health. SEER (Surveillance, Epidemiology, and End Results) Program. Bethesda, Md: National Cancer Institute; 2000.
7. Osmers R, Volksen M, Schauer A. Vaginosonography for early detection of endometrial carcinoma? Lancet. 1990;335:1569-1571.
8. Holst J, Koskela O, von Schoultz B. Endametrial findings following curettage in 2018 women according to age and indications. Ann Chir Gynaecol. 1983;72:274-277.
9. MacKenzie IZ, Bibby JG. Criticol assessment of dilatation and curettage in 1029 women. Lancet. 1978;2:566-568.
10. Smith-Bindmon R, Weiss E, Feldstein V. How thick is too thick? When endometrial thickness should prompt biopsy in postmenopausal women without vaginal bleeding. Ultrasound Obstet Gynecol. 2004;Sep 14 [Epub ahead of print].
11. Purdie DM, Green AC. Epidemiology of endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2001;15:341-354.
12. Einerth Y. Vacuum curettage by the Vabrar method: a simple procedure for endometrial diagnosis. Acta Obstet Gynecol Scand. 1982;61:373-376.
13. Ferenczy A, Shore M, Gurolnicke M, Gelfand MM. The Kevorkian curette: on appraisal of its effectiveness in endometrial evaluation. Obstet Gynecol 1979;54:262-267.
14. Lipscomb GH, Lopatinet SM, Stovall TG, Ling FW. A randomized comparison of the Pipelle, Accurette, and Explora endometrial sampling devices. Am J Obstet Gynecol. 1994;170:591-594.
15. Stovall TG, Photopulos GJ, Poston WM, Ling FW, Sandles LG. Pipelle endometrial sampling in patients with known endometrial carcinoma. Obstet Gynecol. 1991;77:954-956.
16. Stovall TG, Solomon SK, Ling FW. Endometrial sampling prior to hysterectomy [published erratum appears in Obstet Gynecol. 1989;74:105]. Obstet Gynecol. 1989;73:405-409.
17. Stock R, Kanbour A. Prehysterectomy curettage. Obstet Gynecol. 1975;45:537-541.
18. Goldstein RB, Bree RL, Benson CB, et al. Evaluation of the woman with postmenopausal bleeding. Society of Radiologists in Ultrasound-Sponsored Consensus Conference Statement. J Ultrasound Med. 2001;20:1025-1036.
19. deKroon CD, de Bock GH, Dieben SW, Jansen FW. Saline contrast hysterosonography in abnormal uterine bleeding, a systematic review and meta-analysis. Br J Gynaecol. 2003;110(10):938-947.
20. Bree RL, Bowermon RA, Bohm-Velez M, et al. US evaluation of the uterus in patients with postmenopausal bleeding: a positive effect on diagnostic decision making. Radiology. 2000;216:260-264.
21. Dovis PC, O'Neill MJ, Yoder IC, Lee SI, Mueller PR. Sonohysterographic findings of endometrial and subendometrial conditions. Radiographics. 2002;22:803-816.
22. Goldstein SR, Zeltser I, Horan CK, Snyder JR, Schwartz LB. Ultrasonography-based triage for perimenopausal patients with abnormal uterine bleeding. Am J Obstet Gynecol. 1997;177:102-108.
23. Davidson KG, Dubinsky TJ. Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin North Am. 2003;41:769-780.
24. Bettocchi S, Nappi L, Ceci O, Selvaggi L. What does 'diagnostic hysteroscopy' mean today? The role of the new techniques. Curr Opin Obstet Gynecol. 2003;15:303-308.
25. Clark TJ, Voit D, Gupta JK, et al. Accuracy of hysteroscopy in the diagnosis of endometrial cancer and hyperplasia: a systematic quantitative review. JAMA. 2002;288:1610-1621.
26. Van den Bosch T, Vandendael A, Van Schoubroeck D, Wranz PA, Lombard CJ. Combining vaginal ultrasonography and office endometrial sampling in the diagnosis of endometrial disease in postmenopausal women. Obstet Gynecol. 1995;85:349-352.
27. Barton MB, Elmore JG, Fletcher SW. Breast symptoms among women enrolled in a health maintenance organization: frequency, evaluation, and outcome. Ann Intern Med. 1999;130:651-657.
28. Kerlikowske K, Smith-Bindman R, Ljung BM, Grady D. Evaluation of abnormal mammography results and palpable breast abnormalities. Ann Intern Med. 2003;139:274-284.
29. Sterns EE. Age-related breast diagnosis. Can J Surg. 1992;35:41-45.
30. Ljung BM, Drejet A, Chiampi N, et al. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer. 2001;93:263-268.
31. Canadian Association of Radiation Oncologists. Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. CMAJ. 1998;158(suppl 3):S3-S8.
32. Goodson WH III. Clinical breast examination. West J Med. 1996;164:355-358.
33. Kossoff MB. Ultrasound of the breast. World J Surg. 2000;24:143-157.
34. Stavros AT, Thickmon D, Ropp CL, Dennis MA, Parker SH, Sisney GA. Solid breast nodules: use of sonogrophy to distinguish between benign ond malignant lesions. Radiology. 1995;196:123.
35. Podel AF, Coghill DB, Powis SJ. Evidence that the sensitivity is increased and the inadequacy rate decreased when pathologists take aspirates for cytodiagnosis. Cytopathology. 1993;4:161-165.
36. Cohen MB, Rodgers RP, Holes MS, et al. Influence of training and experience in fine-needle aspiration biopsy of the breast. Receiver operating characteristics curve analysis. Arch Pathol Lab Med. 1987;111:518-520.
37. Pisano ED, Fajardo LL, Tsimikas J, et al. Rate of insufficient samples for fine-needle aspiration for nonpalpable breast lesions in a multicenter clinical trial: the Radiologic Diagnostic Oncology Group 5 Study. Cancer. 1998;82:679-688.
38. Lucas JH, Cone DL. Breast cyst aspiration. Am Fam Physician. 2003;68:1983-1986.
39. Hindle WH, Arias RD, Florentine B, Whong J. Lack of utility in clinical practice of cytologic examination of nonbloody cyst fluid from palpable breast cysts. Am J Obstet Gynecol. 2000;182:1300-1305.
40. Institute for Clinical Systems Improvement (ICSI). Breast disease, diagnosis of (formerly breast cancer diagnosis) Available at: www.icsi.org/knowledge/detail.asp?catID=29&item ID=168. Accessed March 23, 2004.
41. Homed H, Coady A, Chaudary MA, Fentiman IS. Follow-up of patients with aspirated breast cysts is necessary. Arch Surg. 1989;124:253-255.
42. Ioffe OB, Berg WA, Silverberg SG, Kumar D. Mammographic-histopathologic correlation of large-core needle biapsies of the breast. Mod Pathol. 1998;11:721-727.
43. Shannon J, Dauglas-Jones AG, Dallimore NS. Conversion to core biopsy in preoperative diagnosis of breast lesions: is it justified by results? J Clin Pathol. 2001;54:762-765.
44. Smith-Bindman R, Chu PW, Miglioretti DL, et al. Comparison of screening mammography in the United States and the United Kingdom. JAMA. 2003;290:2129-1237.
45. Elmore JG, Barton MB, Moceri VM, Polk S, Arena PJ, Fletcher SW. Ten-year risk of false positive screening mammograms and clinical breast examinations. N Engl J Med. 1998;338:1089-1096.
46. May DS, Lee NC, Nadel MR, Henson RM, Miller DS. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women. Am J Roentgenol. 1998;170:97-104.
47. Kerlikowske K, Carney PA, Geller B, et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med. 2000;133:855-863.
48. Barlow WE, Lehman CD, Zheng Y, et al. Performance of diagnostic mammography for women with signs or symptoms of breast cancer. J Natl Cancer Inst. 2002;94:1151-1159.
49. Locker AP, Manhire AR, Stickland V, Caseldine J, Blamey RW. Mammography in symptomatic breast disease. Lancet. 1989;1:887-889.
50. American Cancer Society, Inc. Cancer Facts and Figures 2004. Atlanta, Ga; 2004.
51. Physician Insurers Institute of America. Breast Cancer Study: June 1995. Washington DC: Physician Insurers Association of America; 1995.